These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33278804)

  • 1. Cilostazol Addition to Aspirin could not Reduce the Neurological Deterioration in TOAST Subtypes: ADS Post-Hoc Analysis.
    Aoki J; Iguchi Y; Urabe T; Yamagami H; Todo K; Fujimoto S; Idomari K; Kaneko N; Iwanaga T; Terasaki T; Tanaka R; Yamamoto N; Tsujino A; Nomura K; Abe K; Uno M; Okada Y; Matsuoka H; Yamagata S; Yamamoto Y; Yonehara T; Inoue T; Yagita Y; Kimura K;
    J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105494. PubMed ID: 33278804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
    Toyoda K; Uchiyama S; Yamaguchi T; Easton JD; Kimura K; Hoshino H; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K;
    Lancet Neurol; 2019 Jun; 18(6):539-548. PubMed ID: 31122494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilostazol addition to aspirin may worsen the short-term outcome in patients with large artery disease: ADS subanalysis.
    Aoki J; Kimura K;
    J Neurol Sci; 2024 Jan; 456():122854. PubMed ID: 38154248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tachycardia Changes Increase Neurological Deterioration in Patients with Acute Non-Cardioembolic Stroke: An ADS Post-Hoc Analysis.
    Matsuzono K; Fujimoto S; Aoki J; Ozawa T; Kimura K
    J Atheroscler Thromb; 2023 Jan; 30(1):66-73. PubMed ID: 35283411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom Onset.
    Aoki J; Iguchi Y; Urabe T; Yamagami H; Todo K; Fujimoto S; Idomari K; Kaneko N; Iwanaga T; Terasaki T; Tanaka R; Yamamoto N; Tsujino A; Nomura K; Abe K; Uno M; Okada Y; Matsuoka H; Yamagata S; Yamamoto Y; Yonehara T; Inoue T; Yagita Y; Kimura K;
    J Am Heart Assoc; 2019 Aug; 8(15):e012652. PubMed ID: 31347430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual Antiplatelet Therapy and Outcomes in Acute Mild to Moderate Stroke With Versus Without Large-Artery Atherosclerosis Post Hoc Analysis of ATAMIS.
    Cui Y; Liu QY; Chen HS
    J Am Heart Assoc; 2024 Sep; 13(18):e036318. PubMed ID: 39248249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbleeds and clinical outcome in acute mild stroke patients treated with antiplatelet therapy: ADS post-hoc analysis.
    Aoki J; Iguchi Y; Urabe T; Yamagami H; Todo K; Fujimoto S; Idomari K; Kaneko N; Iwanaga T; Terasaki T; Tanaka R; Yamamoto N; Tsujino A; Nomura K; Abe K; Uno M; Okada Y; Matsuoka H; Yamagata S; Yamamoto Y; Yonehara T; Inoue T; Yagita Y; Kimura K
    J Clin Neurosci; 2021 Jul; 89():216-222. PubMed ID: 34119270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilostazol for Chinese Patients with Aspirin Intolerance after Coronary Drug-Eluting Stent Implantation.
    Dai C; Chen Z; Fu J; Qian J; Ge J
    Thromb Haemost; 2020 May; 120(5):857-865. PubMed ID: 32369856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol Versus Aspirin for Secondary Stroke Prevention: Systematic Review and Meta-Analysis.
    Lin MP; Meschia JF; Gopal N; Barrett KM; Ross OA; Ertekin-Taner N; Brott TG
    J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105581. PubMed ID: 33388632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual antiplatelet therapy with cilostazol in stroke patients with extracranial arterial stenosis or without arterial stenosis: A subgroup analysis of the CSPS.com trial.
    Uchiyama S; Toyoda K; Okamura S; Omae K; Hoshino H; Kimura K; Kitagawa K; Minematsu K; Yamaguchi T
    Int J Stroke; 2023 Apr; 18(4):426-432. PubMed ID: 35762581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Timing for Starting Dual Antiplatelet Treatment With Cilostazol and Recurrent Stroke: A CSPS.com Trial Post Hoc Analysis.
    Toyoda K; Omae K; Hoshino H; Uchiyama S; Kimura K; Miwa K; Minematsu K; Yamaguchi K; Suda Y; Toru S; Kitagawa K; Ihara M; Koga M; Yamaguchi T;
    Neurology; 2022 Mar; 98(10):e983-e992. PubMed ID: 35074890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial.
    Nishiyama Y; Kimura K; Otsuka T; Toyoda K; Uchiyama S; Hoshino H; Sakai N; Okada Y; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T;
    Stroke; 2023 Mar; 54(3):697-705. PubMed ID: 36734235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure during long-term cilostazol-based dual antiplatelet therapy after stroke: a post hoc analysis of the CSPS.com trial.
    Toyoda K; Koga M; Tanaka K; Uchiyama S; Sunami H; Omae K; Kimura K; Hoshino H; Fukuda-Doi M; Miwa K; Koge J; Okada Y; Sakai N; Minematsu K; Yamaguchi T;
    Hypertens Res; 2024 Sep; 47(9):2238-2249. PubMed ID: 38977876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex Difference in the Impact of Dual Antiplatelet Therapy using Cilostazol for Secondary Stroke Prevention: A Sub-Analysis of CSPS.com.
    Hoshino H; Toyoda K; Omae K; Takahashi K; Uchiyama S; Kimura K; Yamaguchi K; Minematsu K; Origasa H; Yamaguchi T
    J Atheroscler Thromb; 2023 Jun; 30(6):675-683. PubMed ID: 36070920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial.
    Lee YS; Bae HJ; Kang DW; Lee SH; Yu K; Park JM; Cho YJ; Hong KS; Kim DE; Kwon SU; Lee KB; Rha JH; Koo J; Han MG; Lee SJ; Lee JH; Jung SW; Lee BC; Kim JS
    Cerebrovasc Dis; 2011; 32(1):65-71. PubMed ID: 21613787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cilostazol on cerebral arteries in secondary prevention of ischemic stroke.
    Guo JJ; Xu E; Lin QY; Zeng GL; Xie HF
    Neurosci Bull; 2009 Dec; 25(6):383-90. PubMed ID: 19927175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
    Toyoda K; Uchiyama S; Hoshino H; Kimura K; Origasa H; Naritomi H; Minematsu K; Yamaguchi T;
    Int J Stroke; 2015 Feb; 10(2):253-8. PubMed ID: 25487817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ipsilateral Nonstenotic Carotid Disease in Minor Ischemic Stroke: an Exploratory Analysis of The POINT Randomized Clinical Trial.
    Bulwa Z; Saleh Velez FG; Brorson JR; Pinto CB
    J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105115. PubMed ID: 33066893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis.
    Uchiyama S; Toyoda K; Omae K; Saita R; Kimura K; Hoshino H; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T
    J Am Heart Assoc; 2021 Oct; 10(20):e022575. PubMed ID: 34622679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 1-Year Outcomes of Triple (Aspirin + Clopidogrel + Cilostazol) Versus Dual Antiplatelet Therapy (Aspirin + Clopidogrel + Placebo) After Implantation of Second-Generation Drug-Eluting Stents into One or More Coronary Arteries: from the DECREASE-PCI Trial.
    Lee CH; Lee JY; Park GM; Lee SW; Kim HS; Choi YJ; Nam CW; Cho JH; Shin WY; Seo JB; Choi SW; Lee JH; Min PK; Her SH; Lee PH; Ahn JM; Park DW; Kang SJ; Kim YH; Lee CW; Park SW; Park SJ
    Am J Cardiol; 2018 Feb; 121(4):423-429. PubMed ID: 29273207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.